Literature DB >> 19132011

On the abundance of EpCAM on cancer stem cells.

Olivier Gires, Christoph A Klein, Patrick A Baeuerle.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19132011     DOI： 10.1038/nrc2499-c1

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  7 in total

1.  Prospective identification of tumorigenic breast cancer cells.

Authors:  Muhammad Al-Hajj; Max S Wicha; Adalberto Benito-Hernandez; Sean J Morrison; Michael F Clarke
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-10       Impact factor: 11.205

2.  A human colon cancer cell capable of initiating tumour growth in immunodeficient mice.

Authors:  Catherine A O'Brien; Aaron Pollett; Steven Gallinger; John E Dick
Journal:  Nature       Date:  2006-11-19       Impact factor: 49.962

3.  Identification and expansion of human colon-cancer-initiating cells.

Authors:  Lucia Ricci-Vitiani; Dario G Lombardi; Emanuela Pilozzi; Mauro Biffoni; Matilde Todaro; Cesare Peschle; Ruggero De Maria
Journal:  Nature       Date:  2006-11-19       Impact factor: 49.962

Review 4.  Cancer stem cells in solid tumours: accumulating evidence and unresolved questions.

Authors:  Jane E Visvader; Geoffrey J Lindeman
Journal:  Nat Rev Cancer       Date:  2008-09-11       Impact factor: 60.716

5.  The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation.

Authors:  Markus Münz; Cuong Kieu; Brigitte Mack; Bärbel Schmitt; Reinhard Zeidler; Olivier Gires
Journal:  Oncogene       Date:  2004-07-29       Impact factor: 9.867

6.  Identification of pancreatic cancer stem cells.

Authors:  Chenwei Li; David G Heidt; Piero Dalerba; Charles F Burant; Lanjing Zhang; Volkan Adsay; Max Wicha; Michael F Clarke; Diane M Simeone
Journal:  Cancer Res       Date:  2007-02-01       Impact factor: 12.701

Review 7.  EpCAM (CD326) finding its role in cancer.

Authors:  P A Baeuerle; O Gires
Journal:  Br J Cancer       Date:  2007-01-09       Impact factor: 7.640
  7 in total
  61 in total

Review 1.  EpCAM and its potential role in tumor-initiating cells.

Authors:  Sannia Imrich; Matthias Hachmeister; Olivier Gires
Journal:  Cell Adh Migr       Date:  2012 Jan-Feb       Impact factor: 3.405

2.  A high-content screen for small-molecule regulators of epithelial cell-adhesion molecule (EpCAM) cleavage yields a robust inhibitor.

Authors:  Jana Ylva Tretter; Kenji Schorpp; Elke Luxenburger; Johannes Trambauer; Harald Steiner; Kamyar Hadian; Olivier Gires; Dierk Niessing
Journal:  J Biol Chem       Date:  2018-04-26       Impact factor: 5.157

Review 3.  Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells.

Authors:  Ugo Testa; Elvira Pelosi; Germana Castelli
Journal:  Med Sci (Basel)       Date:  2018-04-13

4.  Development of an oncolytic HSV vector fully retargeted specifically to cellular EpCAM for virus entry and cell-to-cell spread.

Authors:  T Shibata; H Uchida; T Shiroyama; Y Okubo; T Suzuki; H Ikeda; M Yamaguchi; Y Miyagawa; T Fukuhara; J B Cohen; J C Glorioso; T Watabe; H Hamada; H Tahara
Journal:  Gene Ther       Date:  2016-02-23       Impact factor: 5.250

5.  DARPin-targeting of measles virus: unique bispecificity, effective oncolysis, and enhanced safety.

Authors:  Katrin Friedrich; Jan Rh Hanauer; Steffen Prüfer; Robert C Münch; Iris Völker; Christodoulos Filippis; Christian Jost; Kay-Martin Hanschmann; Roberto Cattaneo; Kah-Whye Peng; Andreas Plückthun; Christian J Buchholz; Klaus Cichutek; Michael D Mühlebach
Journal:  Mol Ther       Date:  2013-02-05       Impact factor: 11.454

6.  Selection and adaptation during metastatic cancer progression.

Authors:  Christoph A Klein
Journal:  Nature       Date:  2013-09-19       Impact factor: 49.962

7.  Antigen-specific T cell response from dendritic cell vaccination using side population cell-associated antigens targets hepatocellular carcinoma.

Authors:  Xiao Li; Zhuochao Zhang; Guoying Lin; Yuanxing Gao; Zhen Yan; Heliang Yin; Bingyi Sun; Fangyuan Wang; Haijun Zhang; Hong Chen; Dayong Cao
Journal:  Tumour Biol       Date:  2016-03-07

8.  Heterodimeric bispecific single-chain variable-fragment antibodies against EpCAM and CD16 induce effective antibody-dependent cellular cytotoxicity against human carcinoma cells.

Authors:  Daniel A Vallera; Bin Zhang; Michelle K Gleason; Seunguk Oh; Louis M Weiner; Dan S Kaufman; Valarie McCullar; Jeffrey S Miller; Michael R Verneris
Journal:  Cancer Biother Radiopharm       Date:  2013-04-23       Impact factor: 3.099

9.  Initial activation of EpCAM cleavage via cell-to-cell contact.

Authors:  Sabine Denzel; Dorothea Maetzel; Brigitte Mack; Carola Eggert; Gabriele Bärr; Olivier Gires
Journal:  BMC Cancer       Date:  2009-11-19       Impact factor: 4.430

10.  The epithelial cell adhesion molecule EpCAM is required for epithelial morphogenesis and integrity during zebrafish epiboly and skin development.

Authors:  Krasimir Slanchev; Thomas J Carney; Marc P Stemmler; Birgit Koschorz; Adam Amsterdam; Heinz Schwarz; Matthias Hammerschmidt
Journal:  PLoS Genet       Date:  2009-07-17       Impact factor: 5.917
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.